General Information of the Compound
Compound ID
CP0077076
Compound Name
1-[6-[(4-methoxyphenyl)methyl]-2-pyridin-2-yl-7,8-dihydro-5H-pyrido[4,3-d]pyrimidin-4-yl]piperidine-4-carboxamide
    Show/Hide
Structure
Formula
C26H30N6O2
Molecular Weight
458.566
Canonical SMILES
COc1ccc(CN2CCc3nc(nc(N4CCC(CC4)C(N)=O)c3C2)-c2ccccn2)cc1
    Show/Hide
InChI
InChI=1S/C26H30N6O2/c1-34-20-7-5-18(6-8-20)16-31-13-11-22-21(17-31)26(32-14-9-19(10-15-32)24(27)33)30-25(29-22)23-4-2-3-12-28-23/h2-8,12,19H,9-11,13-17H2,1H3,(H2,27,33)
    Show/Hide
InChIKey
BXMLUNFOGYHTLD-UHFFFAOYSA-N
Physicochemical Property
logP
2.8072
Rotatable Bonds
6
Heavy Atom Count
34
Polar Areas
97.47
Hydrogen Bond Donor Count
1
Hydrogen Bond Acceptor Count
7
Complexity
34

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 127041883
ChEMBL ID
CHEMBL3747330
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT02042, Cystic fibrosis transmembrane conductance regulator
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000535 CFBE41o- Homo sapiens (Human)  1
1
EC50 = 3467.37 nM
   TI
   LI
   LO
   TS
CL000259 FRT Rattus norvegicus (Rat)  1
1
EC50 = 3500 nM
   TI
   LI
   LO
   TS